Hiperplasia congenita das supra-renais por deficiencia classica da 21-hidroxilase : estudo transversal dos fatores envolvidos na densidade mineral ossea areal em 45 casos
AUTOR(ES)
Patricia oliveira de Almeida Freire
DATA DE PUBLICAÇÃO
2001
RESUMO
INTRODUCTION: Glucocorticoids are essential in the treatment of patients with Congenital Adrenal Hyperplasia (CAH). The opposite actions of glucocorticoids and androgens in bone mass achievement justifies a study of bone mineral density (BMD) inpatients with CAH due to c1assic21-hydroxylase deficiency (CYP21A2). OBJECTIVES: To evaluate BMD in patients with CAH and to investigate the involvement of possible clinieal and laboratory factors. PATIENTS AND METHODS: 45 patients with CAH, 28F:17M, 23 salt losers and 22 with the simple virilizing form, mean age of9.9 years (aged 5.1 to 16.3 years), followed in the Pediatric Endocrinology Unit at State University ofCampinas were studied. Abone densitometry using DEXA teehnique was performed. The values of the L2-L4 BMD z score were calculated in relation to chronologic age (CA) (BMD/CA), height age (RA) (BMDIHA) and bone age (BA) (BMD/BA) and then evaluated aecording compared to sex, CAH type, weight (in kg and z seore), height (in cm and z seore), body mass index (BMI in kglm2 and z score), pubertal development, CA in the diagnosis, CA and BA at the time of bone densitometry, duration of treatment, mean dose and type of glucocorticoids, and 17-hydroxyprogesterone levels 12 and 36 months before bone densitometry. Statistical analysis inc1uded Fisher, Wilcoxon and Kruskal- Wallis tests, with a = 0,05. RESUL TS: BMD/CA areal z score was significant1ylower in females and in patients with longer duration of treatment. Higher values were positively assoeiated with weight and BMI z seores, and with advaneed BA. The BMDIHA areal z score was also positively significant with weight and BMI z scores. BMD/BA areal z score was higher in patients with the smallest differencebetween BA and CA. The BMD/BA was significant1ylower than BMDIHA and BMD/CA, but there was not difference between. CONCLUSION: In patients with CAH CYP21A2 areal BMD/CA and BMDIHA may be overestimated; it in thus important to evaluate BMD in relation to BA. In these patients, weight, BMI and BA were the most important faetors involved in bone mass determination
ASSUNTO(S)
glicocorticoides densitometria androgenos osteoporose
ACESSO AO ARTIGO
http://libdigi.unicamp.br/document/?code=vtls000232375Documentos Relacionados
- Fatores que interferem no crescimento e na altura final de pacientes com hiperplasia congênita das supra-renais por deficiência da 21-hidroxilase
- Hiperplasia congênita das supra-renais por deficiência da 21- hidroxilase: altura final de 27 pacientes com a forma clássica
- Tratamento da hiperplasia supra-renal congênita por deficiência da 21-hidroxilase
- Hiperplasia congenita das supra-renais por deficiencia da 21-hidroxilase : crescimento e composição corporal de crianças com a forma classica, variante perdedora de sal
- Genitoplastia feminizante em meninas portadoras de hiperplasia congenita das supra-renais : aspectos tecnicos e analise dos resultados anatomicos